Nexalin Technology (NXL) Cash from Investing Activities Growth (3y) (2026)

Nexalin Technology (NXL) Cash from Investing Activities Growth (3y) (2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn -253.01%
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -11.91%
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn -41.67%
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -6.88%
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -472.46%
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn -111.03%
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -16.93%
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -40.94%
10 Nexalin Technology 8.72 Mn 6.01 Mn 13,133.00 -0.38%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.38%